Skip to content
Screener

Septerna, Inc. SEPN Price / book

Price / book at other companies

Amgen logo
AmgenAMGN
16.7×-3.4×
Tectonic Therapeutics logo
Tectonic TherapeuticsTECX
2.5×+1.4×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
4.9×+3.8×
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
4.7×+3.0×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
4.6×+2.9×
Schrodinger logo
SchrodingerSDGR
3.7×-0.7×

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%—
Debt / equity0.1×—
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

market cap/total stockholders equity=2.9×

Based on the most recent quarter.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026. Open the filing →

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759

FAQ

What is Septerna, Inc.'s price / book?
Septerna, Inc. (SEPN) reported price / book of 2.9× in Q1 2026.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Septerna, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude